
Sign up to save your podcasts
Or


Five stories, one nerve: the distance between a claim and anyone's ability to check it. SpaceX takes a $4.16B contract to put America's airborne-threat tracking in orbit on its own Starshield platform. A Reuters investigation finds Tesla's "10x safer" math inflated by roughly three, and its robotaxi zones pre-mapped after all. OpenAI hands governments a life-sciences model it once warned could help build bioweapons. A new paper shows per-token AI billing is unauditable by design. And the FDA opens the door to swapping animal studies for computational models, just as fresh research shows where medical AI silently breaks.
By Marcus VorwallerFive stories, one nerve: the distance between a claim and anyone's ability to check it. SpaceX takes a $4.16B contract to put America's airborne-threat tracking in orbit on its own Starshield platform. A Reuters investigation finds Tesla's "10x safer" math inflated by roughly three, and its robotaxi zones pre-mapped after all. OpenAI hands governments a life-sciences model it once warned could help build bioweapons. A new paper shows per-token AI billing is unauditable by design. And the FDA opens the door to swapping animal studies for computational models, just as fresh research shows where medical AI silently breaks.